Miracor Medical
2 known investors
Miracor develops PiCSO (Pressure-controlled intermittent Coronary Sinus Occlusion), a therapy used during percutaneous coronary intervention (PCI) to treat acute myocardial infarction patients. The company focuses on cardiac disease medical technology aimed at improving outcomes and preventing heart failure.